News and blog posts
Decisions about add-on reimbursement for medical devices in France in the period July-September 2018
01
Nov 2018
The French National Authority for Health (HAS) regularly publishes new decisions about add-on reimbursement for medical devices. The decisions made in the period July-September 2018 concern various types of devices. In total, 52 decisions were published.
Read more
31
Oct 2018
In mid-October 2018, the Catalan Agency for Quality and Healthcare Evaluation, AQuAS, published the evaluation of efficacy and safety home-based hospitalization. The authors have concluded that it is a valid patient care option.
Read more
Two new diagnostic codes were added to private reimbursement schedule in England in July/August 2018
30
Oct 2018
The Clinical Coding and Schedule Development Group develops and maintains procedural and diagnostics nomenclature for private payers in England. In July/August new codes for genetic tests, including 18S rRNA gene and sequencing and ELA2 Cyclic Neutropenia Genetic Screen were added to the CCSD Schedule.
Read more
29
Oct 2018
In mid-October 2018, the French Ministry of Solidarity and Health has published an article which describes the change of the financing of the health care system and proposes medium-term strategies for this gradual change. The report has been developed by the Directorate of research, studies, evaluation and statistics (DREES) of this ministry.
Read more
26
Oct 2018
In October 2018, the Austrian HTA body, the Ludwig-Boltzmann Institue (LBI), published the update on the PET/PET-CT topic. The report was done together with the Berlin Technical University.
Read more
25
Oct 2018
In mid-September 2018, the Swiss Federal Council has placed in consultation the first group of actions that are intended to contain costs in the healthcare sector. The suggested measures will be discussed with all relevant healthcare stakeholders (tariff partners, Cantons, industry and patient associations). These measures should save hundreds of millions of Swiss francs in the long term.
Read more
24
Oct 2018
In late July 2018, the regional healthcare agency of the Italian region Emilia Romagna published an a rapid assessment of KLOX LumiHeal ™ system (using photobiomodulation mechanism). The authors conclude that the that the effectiveness of this system is promising, but note that the evidence in these studies is weak (low quality and a low number of subjects), thus only preliminary conclusions can be made.
Read more
23
Oct 2018
Explanation about the coding of CAR-T cell therapy in Switzerland was released by SwissDRG.
Read more
22
Oct 2018
On 6th of September, 2018, the Austrian HTA body, the Ludwig-Boltzmann Institute (LBI-HTA) has released a report on external stimulation of the trigeminal nerve for the prevention and acute treatment of an episodic and chronic migraine. The method was not recommended for inclusion into catalogue of hospital benefits.
Read more
22
Oct 2018
The report presents a summary of reimbursement situation for gastric pacemaker stimulation. Two indications are considered: gastroparesis and obesity. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.
Read more
19
Oct 2018
In mid-August 2018, the Austrian HTA body, the Ludwig-Boltzmann Institute (LBI), has published a health technology assessment in which they have assessed the efficacy and safety of stereotactic radiotherapy (Cyberknife®), proton beam therapy and irreversible electroporation (Nanoknife®) for localized prostate cancer (PCa). It was concluded, there is inadequate and insufficient evidence to show that three evaluated technologies have either a positive impact on survival and quality of life or the ability to prevent or delay prostatectomy.
Read more
18
Oct 2018
The report presents a summary of reimbursement situation for cochlear implants for hearing loss. The only reimbursement within public / statutory health insurance systems is considered. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.
Read more